Preoperative MRI Improves Surgical Outcomes for Prostate Cancer Patients
By MedImaging International staff writers Posted on 17 Jun 2022 |
Imaging techniques are important tools in cancer diagnosis and treatment, but their use remains limited in prostate cancer patients. Systematic prostate biopsies are often used to locate cancerous tissue and guide treatment. While magnetic resonance imaging (MRI) can yield greater insight into tumor characteristics, the extent to which it improves treatment outcomes has not been explored on a wide scale. Now, a study examining the association between preoperative MRI usage and surgical outcomes in prostatectomy patients has demonstrated that MRI may significantly reduce postoperative complications.
In the study, researchers at the Brigham and Women’s Hospital (Boston, MA, USA) examined the association between preoperative MRI usage and surgical outcomes in 19,369 prostatectomy patients from 2004-2015. In analyzing Medicare claims linked to the Surveillance, Epidemiology, and End Results (SEER) database, a cancer registry representative of the US population, the researchers found significant postoperative benefits for patients who received MRI. They identified a reduced likelihood that cancerous cells may remain in the patient after the operation (a “positive surgical margin”) and reduced odds of blood transfusions at 30 and 90 days after the operation. Notably, the researchers found that preoperative MRI was associated with higher likelihood of further treatment, but they hypothesize that MRI may be associated with more resource-intensive cancer care overall.
While the proportion of prostatectomy patients receiving preoperative MRI increased over the study period nearly tenfold, from 2.9% to 28.2%, the use of MRI in different regional health care markets varied widely, ranging from 0% to 28.8%. Factors such as cost, health literacy and availability of imaging may affect whether a man with prostate cancer receives an MRI, according to the researchers.
“Overdiagnosis, overtreatment and toxicity associated with treatment are big problems with prostate cancer, but MRI can help reduce unnecessary biopsies and improve surgical outcomes,” said corresponding author Alexander Cole, MD, of the Brigham’s Division of Urology. “Work by our team has shown that early diagnosis and access to care really makes a difference for prostate cancer treatment.”
Related Links:
Brigham and Women’s Hospital
Latest MRI News
- Groundbreaking AI-Powered Software Significantly Enhances Brain MRI
- MRI Predicts Patient Outcomes and Tumor Recurrence in Rectal Cancer Patients
- Portable MRI System Dramatically Cuts Time-To-Scan vs. Conventional MRI in Stroke Patients
- Novel Model Identifies Focal Cortical Dysplasia Lesion from MRI Scans
- AI-Enhanced MRI Improves Diagnosis of Brain Disorders
- New Cardiac MRI Strategy Guides Ablation Procedures for Complex Tachycardias
- AI Model Achieves Clinical Expert Level Accuracy in Analyzing Complex MRIs and 3D Medical Scans
- MRI Provides Early Warning System for Glioblastoma Growth
- AI Algorithm Analyzes MRI Scans to Determine Best Rectal Cancer Treatment Strategy
- AI Software Uses MRI Scans to Automatically Segment Key Brain Structures for Improved Radiation Therapy Planning
- AI Software Analyzes Neuroimaging Data and Patient Information to Diagnose 10 Types of Dementia
- Metamaterials to Make MRI Scans Faster, Cheaper, and More Accurate
- Deep Learning Enables Accurate, Automated Quality Control Image Assessment for Liver MR Elastography
- Deep Learning-Based AI for Prostate MRI Helps Improve Risk Assessment and Avoid Unnecessary Biopsies
- Breakthrough Heart MRI Technique Accurately Predicts Heart Failure Risk in General Population
- MRI Could Help Doctors Predict More Aggressive Prostate Cancer in Patients